An Update on Scientific Advances and Clinical Strategies in Alzheimer’s Disease from CTAD 2015

Pre-Activity Questions

Pre-Activity Questions

How frequently do you CURRENTLY do each of the following? *

Please use the scale: 1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable to me

	1	2	3	4	5	N/A
I recommend to my patients at high risk for Alzheimer’s disease participation in prevention/early recognition trials.	I recommend to my patients at high risk for Alzheimer’s disease participation in prevention/early recognition trials. - 1	I recommend to my patients at high risk for Alzheimer’s disease participation in prevention/early recognition trials. - 2	I recommend to my patients at high risk for Alzheimer’s disease participation in prevention/early recognition trials. - 3	I recommend to my patients at high risk for Alzheimer’s disease participation in prevention/early recognition trials. - 4	I recommend to my patients at high risk for Alzheimer’s disease participation in prevention/early recognition trials. - 5	I recommend to my patients at high risk for Alzheimer’s disease participation in prevention/early recognition trials. - N/A
I recommend lifestyle modifications to my patients at high risk for Alzheimer’s disease as a strategy to delay cognitive impairment.	I recommend lifestyle modifications to my patients at high risk for Alzheimer’s disease as a strategy to delay cognitive impairment. - 1	I recommend lifestyle modifications to my patients at high risk for Alzheimer’s disease as a strategy to delay cognitive impairment. - 2	I recommend lifestyle modifications to my patients at high risk for Alzheimer’s disease as a strategy to delay cognitive impairment. - 3	I recommend lifestyle modifications to my patients at high risk for Alzheimer’s disease as a strategy to delay cognitive impairment. - 4	I recommend lifestyle modifications to my patients at high risk for Alzheimer’s disease as a strategy to delay cognitive impairment. - 5	I recommend lifestyle modifications to my patients at high risk for Alzheimer’s disease as a strategy to delay cognitive impairment. - N/A
I stay up-to-date on emerging clinical trial data related to the diagnosis and treatment of Alzheimer’s disease.	I stay up-to-date on emerging clinical trial data related to the diagnosis and treatment of Alzheimer’s disease. - 1	I stay up-to-date on emerging clinical trial data related to the diagnosis and treatment of Alzheimer’s disease. - 2	I stay up-to-date on emerging clinical trial data related to the diagnosis and treatment of Alzheimer’s disease. - 3	I stay up-to-date on emerging clinical trial data related to the diagnosis and treatment of Alzheimer’s disease. - 4	I stay up-to-date on emerging clinical trial data related to the diagnosis and treatment of Alzheimer’s disease. - 5	I stay up-to-date on emerging clinical trial data related to the diagnosis and treatment of Alzheimer’s disease. - N/A

Leave this field blank